The risk of pneumocystis pneumonia in patients of autoimmune blistering disease - reply to letter entitled “Pemphigus management guidelines: A life saving perspective.”

Kyle T. Amber

Correspondence

Correspondence: Kyle T. Amber MD, Assistant Professor, Division of Dermatology, Department of Otorhinolaryngology, Department of Internal Medicine, 707 S Wood St. Suite 220, Chicago, IL 60612, , P: 312-563-5990, F: 312-942-7778, ORCID ID: 0000-0002-2906-2454

AffiliationsDivision of Dermatology, Rush University Medical Center, Chicago, IllinoisDepartment of Internal Medicine, Rush University Medical Center, Chicago, IllinoisSearch for articles by this author

View original article

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Like

Share Bookmark

0 0 0 0 0 0 0

More from this channel

The risk of pneumocystis pneumonia in patients of autoimmune blistering disease - reply to letter entitled “Pemphigus management guidelines: A life saving perspective.”

Comments (0)